🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 53630X104
- Market Cap
- Small Cap
Business: Lipocine, Inc. is a specialty pharmaceutical company developing innovative pharmaceutical products for use in men's and women's health using its proprietary drug delivery technologies. Lipocine's lead product candidate, LPCN 1021, demonstrated positive top-line efficacy results in Phase 3 testing and is targeted for testosterone replacement therapy. LPCN 1107, which has the potential to become the first oral hydroxyprogesterone caproate product indicated for the prevention of recurrent preterm birth is currently in Phase 1 testing.
Company Contact
- CEO
- Mahesh V. Patel
- CFO
- Morgan R. Brown
- Headquarters
- 675 Arapeen Drive, Suite 202, Salt Lake City, UT 84108
- Phone
- 801-994-7383
- Investor Relations
- Morgan R. Brown · 801-994-7383 · mb@lipocine.com